Publications

5491 Results

Smoking modifies pancreatic cancer risk loci on 2q21.3

Authors
E Mocci;P Kundu;W Wheeler;A Arslan;L Freeman;P Bracci;P Goodman;D Albanes;C Fuchs;JM Gaziano;IM Thompson;B Wolpin;H Risch;P Kraft;N Chatterjee;A Klein;R Stolzenberg-Solomon
Journal / Conference
Cancer Research Jun 1;81(11):3134-3143; Feb 11;canres.3267.2020. doi: 10.1158/0008-5472.CAN-20-3267. Online ahead of print
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID33574088
PMC
PMC8178175
Study Number(s)
S0000

A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies

Authors
S Aleshin-Guendel;J Lange;P Goodman;N Weiss
Journal / Conference
Evaluation and the Health Professions Mar;44(1):42-49
Year
2021
Research Committee(s)
Prevention and Epidemiology
PMID
PMID33506704
PMC
PMC8279086
Study Number(s)
S0000

Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (LungMAP SWOG S1400GEN)

Authors
J Roth;M Trivedi;S Gray;D Patrick;D Delaney;K Watabayashi;P Litwin;P Shah;K Crew;M Yee;M Redman;J Unger;V Papadimitrakopoulou;J Johnson;K Kelly;D Gandara;RS Herbst;D Hershman;S Ramsey
Journal / Conference
Journal of Oncology Practice Nov;17(11): e1821-e1829
Year
2021
Research Committee(s)
Cancer Care Delivery and Lung
PMID
PMID33797955

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Authors
S Pal;C Tangen;I Thompson;N Balzer-Haas;D George;D Heng;B Shuch;M Stein;M Tretiakova;P Humphrey;A Adeniran;V Narayan;G Bjarnason;U Vaishampayan;A Alva;T Zhang;S Cole;M Plets;J Wright;P Lara
Journal / Conference
Lancet Feb 20;397(10275):695-703. doi: 10.1016/S0140-6736(21)00152-5. Epub 2021 Feb 13.
Year
2021
Research Committee(s)
Genitourinary
PMID
PMID33592176
PMC
PMC8687736
Study Number(s)
S1500

Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study

Authors
SK Pal;C Tangen;IM Thompson;N Balzer-Haas;D George;D Heng;B Shuch;M Stein;M Tretiakova;P Humphrey;A Adeniran;V Narayan;G Bjarnason;U Vaishampayan;A Alva;T Zhang;S Cole;M Plets;J Wright;P Lara
Journal / Conference
J Clin Oncol 39, 2021 (suppl 6; abstr 270); ASCO GU Cancers Sympos (Feb 13-15, 2021), oral
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
S1500

Meta-analysis in more than 80,000 men of African ancestry identified eight novel variants associated with prostate cancer

Authors
F Chen;R Madduri;X Sheng;A Rodriguez;A Chou;B Darst;A Hsing;P Goodman;IM Thompson;EA Klein;J Witte;W Blot;D Conti;JM Gaziano;A Justice;C Haiman
Journal / Conference
American Association for Cancer Research (Week 1: April 10-15; Week 2: May 17-21, 2021 virtual) LBA, oral
Year
2021
Research Committee(s)
Cancer Control and Prevention and Epidemiology
Study Number(s)
S0000, SWOG-9217

Persistent disparity: Socioeconomic deprivation and cancer outcomes in patients treated in SWOG NCTN clinical trials

Authors
J Unger;A Moseley;C Cheung;R Osarogiagbon;B Symington;S Ramsey;D Hershman
Journal / Conference
Journal of Clinical Oncology Apr 20;39(12):1339-1348
Year
2021
Research Committee(s)
Cancer Care Delivery
PMID
PMID33729825
PMC
PMC8078474

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

Authors
E Lopez de Maturana;J Rodriguez;L Alonso;O Lao;E Molina-Montes;P Gomez-Rubio;R Lawlor;D Albanes;JM Gaziano;P Goodman;M Marti-Renom;F Real;N Malats
Journal / Conference
Genome Medicine Feb 1;13(1):15
Year
2021
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID33517887
PMC
PMC7849104
Study Number(s)
S0000, SWOG-9217

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

Authors
M Huynh-Le;C Fan;R Karunamuni;W Thompson;ME Martinez;R Eeles;C Tangen;D Albanes;M-E Parent;J Hu;I Mills;O Andreassen;A Dale;T Seibert
Journal / Conference
Nature Communications Feb 23;12(1):1236
Year
2021
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID33623038
PMC
PMC7902617
Study Number(s)
S0000, SWOG-9217

Associations Between Complete Remission and 2-3 Year Survival Following 7+3 Induction for Acute Myeloid Leukemia

Authors
M Othus;G Garcia-Manero;J Godwin;J Weick;D Stirewalt;F Appelbaum;H Erba;E Estey
Journal / Conference
Leukemia & Lymphoma, Aug;62(8):1967-1972; Mar 10;1-6. doi: 10.1080/10428194.2021.1885663. Online ahead of print.2021
Year
2021
Research Committee(s)
Leukemia
PMID
PMID3719833
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333